Evidence map›Paper›PMID 28822021›Full record

ArticleMetabolic brain disease2017

Morus nigra and its major phenolic, syringic acid, have antidepressant-like and neuroprotective effects in mice.

Ana Paula Dalmagro, Anderson Camargo, Ana Lúcia Bertarello Zeni

Abstract read
PubMed Publisher
In one paragraph

Article in Metabolic brain disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Black Mulberries (Foods (Basel, Switzerland) · 2024
    Article
  5. Neuroprotective effects of total phenolics fromFrontiers in pharmacology · 2024
    Article
  6. The Emerging Importance of Cirsimaritin in Type 2 Diabetes Treatment.International journal of molecular sciences · 2023
    Article
  7. Article
  8. The Anxiolytic Activity ofPharmaceuticals (Basel, Switzerland) · 2022
    Article
  9. Review
  10. Article
  11. Review
  12. Methanolic Extract ofDrug design, development and therapy · 2022
    Article
  13. Article
  14. Antioxidant-RichPlants (Basel, Switzerland) · 2021
    Article
  15. Article
  16. Review
  17. Evaluation and comparison of the antidepressant-like activity ofResearch in pharmaceutical sciences · 2019
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ana Paula DalmagroPrograma de Pós-Graduação em Química, Departamento de Química, Universidade Regional de Blumenau, Blumenau, Santa Catarina, CEP 89030-903, Brazil.
Anderson CamargoLaboratório de Avaliação de Substâncias Bioativas, Departamento de Ciências Naturais, Universidade Regional de Blumenau, CEP 89030-903, Campus I, Blumenau, SC, 89012-900, Brazil.
Ana Lúcia Bertarello ZeniPrograma de Pós-Graduação em Química, Departamento de Química, Universidade Regional de Blumenau, Blumenau, Santa Catarina, CEP 89030-903, Brazil. anazeni@furb.br.
Universidade Regional de Blumenau · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Depression is a disorder with a high incidence that has been increasing worldwide although the pathophysiology remains unclear. Moreover, some studies revealed a higher concentration of glutamate and oxidative stress in the patients' brain, which causes cell death by excitotoxicity. Morus nigra L. is known as black mulberry and its leaves are popularly used to treat affections related to menopause, obesity and high cholesterol. M. nigra leaves are a rich fount of phenolics which well-known by the antioxidant property. Herein, we examined the phenolic profile and the antidepressant-like effect of the Morus nigra aqueous extract (MN) and its major phenolic constituent, syringic acid (SA). Furthermore, the involvement of antioxidant and neuroprotective activities were further evaluated. Our results show that acute and subchronic MN or SA administration exerted antidepressant-like property in the behavioral testes in mice. The results suggest that the antidepressant-like effect of MN, at least in part, could be due to the SA influence. Moreover, the observed effect involves the nitro-oxidative system modulation in both the serum and brain of mice. Furthermore, MN or SA was able to contain the glutamate-induced cell death in the hippocampal and cortical slices implicating the neuroprotection activity in the antidepressant-like effect.

Indexed as

AnimalsAntidepressive AgentsBehavior, AnimalBrainDepressionGallic AcidLipid PeroxidationMaleMiceMorusMotor ActivityNeuroprotective AgentsOxidative StressPlant ExtractsAntidepressive AgentsGallic AcidNeuroprotective AgentsPlant Extractssyringic acidAntidepressantMorus nigraNeuprotectiveSyringic acid

Identifiers

PMID28822021
OpenAlexW2745962230

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.